-
-
-
-
-
-
-
Gain Therapeutics, Inc. (GANX) Reports In-Line Q3 EPS
-
-
-
-
-
-
-
Gain Therapeutics (GANX) Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Gain Therapeutics (GANX)
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Gain Therapeutics (GANX)
-
-
-
-
-
-
-
Gain Therapeutics (GANX) Presents GT-02287 Data
-
-
-
416,876 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

